<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Valentin Williamson | Activity</title>
	<link>http://toxicdolls.com/members/dinnerleg4/activity/</link>
	<atom:link href="http://toxicdolls.com/members/dinnerleg4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Valentin Williamson.</description>
	<lastBuildDate>Mon, 09 Nov 2026 22:28:27 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">80c99ce0421d9642bc8070252ff99617</guid>
				<title>Valentin Williamson posted an update: 53 [95% Confidence Interval (CI), 13.91-30.29]); younger [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/61461/</link>
				<pubDate>Sat, 19 Jul 2025 09:57:08 +0000</pubDate>

									<content:encoded><![CDATA[<p>53 [95% Confidence Interval (CI), 13.91-30.29]); younger donor age (OR 3.72 [95% CI, 2.83-4.89]), longer time until the next organ offer (OR 3.48 [95% CI, 2.65-4.57]), and greater trust in their transplant physician (OR 1.03 [95% CI, 1.00-1.06]). Candidates with a lower likelihood of acceptance had been waitlisted longer (OR 0.97 per month [95%&hellip;<span class="activity-read-more" id="activity-read-more-61461"><a href="http://toxicdolls.com/activity-2/p/61461/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e17817edc842e1a87219dc97d5b39961</guid>
				<title>Valentin Williamson posted an update: In-stent restenosis (ISR) is one of the main limitations of [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/43710/</link>
				<pubDate>Fri, 11 Jul 2025 10:01:49 +0000</pubDate>

									<content:encoded><![CDATA[<p>In-stent restenosis (ISR) is one of the main limitations of percutaneous coronary intervention (PCI) therapy with drug-eluting stents (DES) implantation. <a href="https://www.selleckchem.com/products/ha15.html" rel="nofollow ugc">HA15 molecular weight</a> The aim of this study was to determine if circulating microRNAs (miRNAs) have diagnostic capability for determining ISR in a cohort of matched patients. Blood samples were&hellip;<span class="activity-read-more" id="activity-read-more-43710"><a href="http://toxicdolls.com/activity-2/p/43710/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">99bb584c3cef3295af2876ca2a95f38d</guid>
				<title>Valentin Williamson posted an update: 6, 22.2 and 25.8 months, respectively. Anemia, lymphopenia, a [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/40076/</link>
				<pubDate>Thu, 10 Jul 2025 07:50:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>6, 22.2 and 25.8 months, respectively. Anemia, lymphopenia, and neutropenia were the most common adverse events. NDLS treatment was overall well-tolerated without any new safety concerns.</p>
<p> Biweekly NDLS for &gt;20 cycles was effective and well-tolerated in patients with mCRPC. NDLS can potentially be used for long-term management, which may b&hellip;<span class="activity-read-more" id="activity-read-more-40076"><a href="http://toxicdolls.com/activity-2/p/40076/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ab8a370f968a3a4f3ea7e8eaf3c676eb</guid>
				<title>Valentin Williamson became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/39985/</link>
				<pubDate>Thu, 10 Jul 2025 07:25:09 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>